> NeoPharm says that the FDA will accept interim efficacy data for a late-stage trial of its experimental brain cancer treatment. NeoPharm says it expects full enrollment in the trial by the end of the year. Story
> Caraco Pharmaceutical has won tentative FDA approval for a generic version of Sanofi Aventis' Ambien. Report
> Caraco also announced FDA approval for a new strength of clozapine. Release
> Researchers say that the long-term use of aspirin lowers the risk of colon cancer, but only at the risk of gastrointestinal bleeding. Story
> The FDA has approved the use of Solvay's Aceon for patients with stable coronary artery disease. Report
> A federal judge has ruled that a group of generic drug makers did not infringe on Pfizer's patent for Neurontin -- an anti-convulsant -- by making a low-cost knockoff. Article
And Finally… In a report sure to cheer obesity drug developers, residents in 49 states got fatter in recent years, with Alabama's deep-fried culture leading the way. Article